Prime Discoveries
Prime Discoveries is a biotechnology company founded in 2017 in New York City, specializing in developing rapid, scalable diagnostic tests for laboratories. Their mission is to provide high-throughput, automated testing solutions for infectious diseases, including COVID-19 and various variants, leveraging advanced technologies such as RT-LAMP, PCR, and NGS. They collaborate with academic institutions and are supported by leading investors, aiming to enhance laboratory testing capabilities worldwide.
Industries
Nr. of Employees
small (1-50)
Prime Discoveries
Products
Rapid RT‑LAMP SARS‑CoV‑2 detection assay
Extraction‑less RT‑LAMP assay for detection of SARS‑CoV‑2 designed for rapid (<30–45 min) and high‑throughput laboratory use, compatible with automation and multiplex formats.
Rapid PCR‑based variant genotyping assay
PCR genotyping assays optimized for detection of viral variants and mutations with workflows under 60 minutes and compatibility with common extraction protocols and qPCR instruments.
Respiratory multiplex detection panel (RT‑LAMP/PCR)
Multiplex panels for respiratory pathogens (SARS‑CoV‑2, Influenza A/B, RSV A/B) using RT‑LAMP and PCR formats for rapid detection and high throughput processing.
STI multiplex detection panel (LAMP/PCR)
Assay panels for sexually transmitted infections supporting both isothermal and PCR workflows with single and multiplex options for panels of bacterial, viral, and fungal targets.
Rapid PCR assay for Candida auris (extraction‑less compatible)
PCR‑based assay for detection of Candida auris with high analytical sensitivity and specificity, designed to work with extraction‑less collection media for direct sample testing.
NGS full‑genome sequencing workflow for SARS‑CoV‑2
Rapid NGS workflow optimized for full‑genome SARS‑CoV‑2 sequencing with rapid prep, support for small batches, high read throughput, and automated analysis for variant identification.
Rapid RT‑LAMP SARS‑CoV‑2 detection assay
Extraction‑less RT‑LAMP assay for detection of SARS‑CoV‑2 designed for rapid (<30–45 min) and high‑throughput laboratory use, compatible with automation and multiplex formats.
Rapid PCR‑based variant genotyping assay
PCR genotyping assays optimized for detection of viral variants and mutations with workflows under 60 minutes and compatibility with common extraction protocols and qPCR instruments.
Respiratory multiplex detection panel (RT‑LAMP/PCR)
Multiplex panels for respiratory pathogens (SARS‑CoV‑2, Influenza A/B, RSV A/B) using RT‑LAMP and PCR formats for rapid detection and high throughput processing.
STI multiplex detection panel (LAMP/PCR)
Assay panels for sexually transmitted infections supporting both isothermal and PCR workflows with single and multiplex options for panels of bacterial, viral, and fungal targets.
Rapid PCR assay for Candida auris (extraction‑less compatible)
PCR‑based assay for detection of Candida auris with high analytical sensitivity and specificity, designed to work with extraction‑less collection media for direct sample testing.
NGS full‑genome sequencing workflow for SARS‑CoV‑2
Rapid NGS workflow optimized for full‑genome SARS‑CoV‑2 sequencing with rapid prep, support for small batches, high read throughput, and automated analysis for variant identification.
Services
Development and adaptation of molecular diagnostic assays (RT‑LAMP, PCR, NGS) to match laboratory workflows, instrumentation, and throughput needs, with specialist support during implementation.
Integration of automation, pooling, and multiplexing strategies with partner CLIA labs and automated liquid handlers to scale sample processing to thousands of samples.
Full‑genome sequencing workflows for pathogen surveillance, including rapid prep workflows, barcoding/pooling, automated analysis pipelines, and variant/strain reporting.
Coordination with ISO‑certified contract manufacturers and multiple reagent suppliers to support reagent supply and manufacturing timelines for laboratory assays.
Development and adaptation of molecular diagnostic assays (RT‑LAMP, PCR, NGS) to match laboratory workflows, instrumentation, and throughput needs, with specialist support during implementation.
Integration of automation, pooling, and multiplexing strategies with partner CLIA labs and automated liquid handlers to scale sample processing to thousands of samples.
Full‑genome sequencing workflows for pathogen surveillance, including rapid prep workflows, barcoding/pooling, automated analysis pipelines, and variant/strain reporting.
Coordination with ISO‑certified contract manufacturers and multiple reagent suppliers to support reagent supply and manufacturing timelines for laboratory assays.
Expertise Areas
- Diagnostic assay development
- Isothermal amplification (RT‑LAMP)
- Rapid PCR assay design and genotyping
- NGS‑based genomic surveillance and variant detection
Key Technologies
- RT‑LAMP (extraction‑less isothermal amplification)
- Rapid PCR / qPCR genotyping
- Next‑generation sequencing (Illumina‑based workflows)
- Automated liquid handling